Karyopharm Announces FDA Approval of XPOVIO® (selinexor) for the Treatment of Patients with Relapsed or Refractory
Karyopharm Therapeutics Empresa reivindicada
Karyopharm is an innovation-driven pharmaceutical company whose core technology leverages the inhibition of nuclear export as a mechanism to treat patients with cancer and other medical conditions consulte Mais informação
Constant change. Lots of new people with new ways of working and expectations
Qual é a melhor parte das suas compensações?
Base salary since the stock is challenging.
No que os seus colegas poderiam melhorar e o que faria vocês trabalharem mais unidos?
Open mind. Willingness to take ownership/
O que você mais gosta nos lideres?
They seem to be working more collaboratively than before.
O que faz você mais feliz no trabalho?
Providing value and being respected and appreciated for it.
Qual é a coisa mais positiva da cultura e do ambiente da sua empresa?
Seems to be evolving. Less blame and threatening than before.
Other Employee Reviews for Karyopharm Therapeutics
×